Jinyu Bio-technology Future Growth

Future criteria checks 5/6

Jinyu Bio-technology is forecast to grow earnings and revenue by 47.1% and 27.4% per annum respectively. EPS is expected to grow by 43.4% per annum. Return on equity is forecast to be 7.4% in 3 years.

Key information

47.1%

Earnings growth rate

43.4%

EPS growth rate

Biotechs earnings growth	43.6%
Revenue growth rate	27.4%
Future return on equity	7.4%
Analyst coverage	Good
Last updated	14 Nov 2024

Recent future growth updates

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Sep 02

Recent updates

The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Sep 04

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Sep 02

Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Jun 16

Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

Apr 30

There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Mar 21

Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Feb 28

Earnings and Revenue Growth Forecasts

SHSE:600201 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	2,471	531	N/A	651	4
12/31/2025	1,926	384	N/A	445	6
12/31/2024	1,459	259	N/A	468	3
9/30/2024	1,350	165	148	331	N/A
6/30/2024	1,525	272	157	405	N/A
3/31/2024	1,582	283	223	496	N/A
12/31/2023	1,598	284	142	415	N/A
9/30/2023	1,639	289	221	429	N/A
6/30/2023	1,572	240	280	445	N/A
3/31/2023	1,551	236	151	331	N/A
12/31/2022	1,529	211	155	345	N/A
9/30/2022	1,546	174	233	486	N/A
6/30/2022	1,578	229	188	493	N/A
3/31/2022	1,599	252	124	484	N/A
12/31/2021	1,776	382	160	533	N/A
9/30/2021	1,813	529	245	554	N/A
6/30/2021	1,798	482	379	673	N/A
3/31/2021	1,735	467	446	677	N/A
12/31/2020	1,582	406	471	700	N/A
9/30/2020	1,387	268	415	684	N/A
6/30/2020	1,240	234	209	481	N/A
3/31/2020	1,159	213	239	526	N/A
12/31/2019	1,127	221	98	405	N/A
9/30/2019	1,312	322	-13	349	N/A
6/30/2019	1,646	565	-63	408	N/A
3/31/2019	1,673	617	-221	293	N/A
12/31/2018	1,897	754	-123	422	N/A
9/30/2018	2,008	869	196	636	N/A
6/30/2018	1,909	842	N/A	713	N/A
3/31/2018	1,997	900	N/A	840	N/A
12/31/2017	1,901	870	N/A	945	N/A
9/30/2017	1,809	842	N/A	935	N/A
6/30/2017	1,651	748	N/A	910	N/A
3/31/2017	1,635	719	N/A	824	N/A
12/31/2016	1,517	645	N/A	756	N/A
9/30/2016	1,393	561	N/A	764	N/A
6/30/2016	1,309	518	N/A	588	N/A
3/31/2016	1,252	505	N/A	583	N/A
12/31/2015	1,247	480	N/A	494	N/A
9/30/2015	1,210	499	N/A	389	N/A
6/30/2015	1,116	436	N/A	501	N/A
3/31/2015	1,063	433	N/A	460	N/A
12/31/2014	1,063	404	N/A	585	N/A
9/30/2014	921	346	N/A	837	N/A
6/30/2014	874	308	N/A	785	N/A
3/31/2014	849	277	N/A	809	N/A
12/31/2013	671	251	N/A	649	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600201's forecast earnings growth (47.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 600201's earnings (47.1% per year) are forecast to grow faster than the CN market (26% per year).

High Growth Earnings: 600201's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600201's revenue (27.4% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 600201's revenue (27.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600201's Return on Equity is forecast to be low in 3 years time (7.4%).

Jinyu Bio-technology Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Consensus revenue estimates fall by 17%

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Price target decreased by 12% to CN¥8.34

Consensus revenue estimates fall by 13%

Price target decreased by 8.9% to CN¥9.38

Price target decreased by 8.0% to CN¥9.48

Recent updates

Jinyu Bio-technology Co., Ltd. (SHSE:600201) announces an Equity Buyback for 15,984,015 shares, representing 1.43% for CNY 160 million.

Jinyu Bio-technology Co., Ltd. (SHSE:600201) announces an Equity Buyback for 15,984,015 shares, representing 1.43% for CNY 160 million.

New minor risk - Profit margin trend

Third quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.14 in 3Q 2023)

Jinyu Bio-technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 17%

Consensus revenue estimates fall by 17%

The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Price target decreased by 12% to CN¥8.34

Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Jinyu Bio-technology Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Investor sentiment deteriorates as stock falls 20%

Now 20% overvalued after recent price rise

New minor risk - Shareholder dilution

Jinyu Bio-technology Co., Ltd., Annual General Meeting, May 27, 2024

Consensus revenue estimates fall by 13%

Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

Price target decreased by 8.9% to CN¥9.38

Jinyu Bio-technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Price target decreased by 8.0% to CN¥9.48

There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Now 20% overvalued

Now 26% overvalued

Investor sentiment deteriorates as stock falls 17%

Jinyu Bio-technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 10% to CN¥10.33

Second quarter 2023 earnings released: EPS: CN¥0.024 (vs CN¥0.02 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.07 in 1Q 2022)

Price target increased by 8.4% to CN¥11.82

Jinyu Bio-technology Co., Ltd. announced that it expects to receive CNY 799.999997 million in funding from Inner Mongolia Jinyu Biological Holdings Co., Ltd., and other investors

Price target increased to CN¥11.87

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.041 in 2Q 2021)

Consensus revenue estimates fall by 20%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Jinyu Bio-technology Co., Ltd. (SHSE:600201) announces an Equity Buyback for CNY 300 million worth of its shares.

Price target decreased to CN¥22.80

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.041 (vs CN¥0.028 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.13 in 1Q 2020)

New 90-day low: CN¥20.00

New 90-day low: CN¥21.54

New 90-day low: CN¥22.60

Third quarter earnings released

Third-quarter earnings released: Revenue beats expectations, earnings disappoint

New 90-day low: CN¥23.40

Jinyu Bio-technology Co., Ltd. to Report Q3, 2020 Results on Oct 23, 2020

Price target raised to CN¥30.56

Earnings released

Jinyu Bio-technology Co., Ltd. to Report First Half, 2020 Results on Aug 15, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies